Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

When clinical practice demands to go beyond statistics: Adjuvant chemotherapy of colon cancer. The 3 vs 6 month story

Moderated panel discussion on clinical conditions and Q&A

Date

11 Sep 2017

Session

When clinical practice demands to go beyond statistics: Adjuvant chemotherapy of colon cancer. The 3 vs 6 month story

Topics

Cytotoxic Therapy;  Colon and Rectal Cancer

Presenters

Ioannis Souglakos

Authors

A. Cervantes1, J.A. Meyerhardt2, A.F. Shields3, A. Sobrero4, I. Souglakos5

Author affiliations

  • 1 Medical Oncology  , Hospital Clinico Universitario de Valencia, 46010 - Valencia/ES
  • 2 Medical Oncology, Dana-Farber Cancer Institute, 2215 - Boston/US
  • 3 Dept Of Oncology, Karmanos Cancer Institute, 48201-2013 - Detroit/US
  • 4 -, IRCCS AOU San Martino - IST-Istituto Nazionale per la Ricerca sul Cancro, 16132 - Genova/IT
  • 5 Division Of Internal Medicine, University of Crete, - - Heraklion/GR
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.